Resource Use for COVID-19 Pneumonia in the Accelerating COVID-19 Therapeutic Interventions and Vaccines Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Resource Use for COVID-19 Pneumonia in the Accelerating COVID-19 Therapeutic Interventions and Vaccines Trial

Published:2024-08 Issue: Volume: Page:100095
ISSN:2949-7884
Container-title:CHEST Critical Care
language:en
Short-container-title:CHEST Critical Care

Author:

Lachiewicz Anne M.^ORCID,Shah Miloni,Der Tatyana^ORCID,Cyr Derek,Al-Khalidi Hussein R.^ORCID,Lindsell Christopher^ORCID,Iyer Vivek^ORCID,Khan Akram^ORCID,Panettieri Reynold,Rauseo Adriana M.^ORCID,Maillo Martin^ORCID,Schmid Andreas,Jagpal Sugeet,Powderly William G.^ORCID,Bozzette Samuel A.

Funder

Doris Duke Charitable Foundation

US Department of Health and Human Services

NCATS

Publisher

Elsevier BV

Reference16 articles.

1. The impact of pathogens on sepsis prevalence and outcome;Dyck;Pathogens,2024

2. Abatacept, cenicriviroc, or infliximab for treatment of adults hospitalized with COVID-19 pneumonia: a randomized clinical trial;O’Halloran;JAMA,2023

3. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): designing master protocols for evaluation of candidate COVID-19 therapeutics;LaVange;Ann Intern Med,2021

4. Oxygen-free days as an outcome measure in clinical trials of therapies for COVID-19 and other causes of new-onset hypoxemia;Moskowitz;Chest,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP